Ata uhi

Preparation and Characterization of Hydrophobin 4-Coated Liposomes for Doxorubicin Delivery to Cancer Cells

<b>Background:</b> The properties of nanoparticle surfaces are crucial in influencing their interaction with biological environments, as well as their stability, biocompatibility, targeting abilities, and cellular uptake. Hydrophobin 4 (HFB4) is a class II HFB protein produced by filamen...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Fatma Hande Osmanagaoglu (Author), Aysegul Ekmekcioglu (Author), Busel Ozcan (Author), Gunseli Bayram Akcapinar (Author), Meltem Muftuoglu (Author)
Hōputu:	Pukapuka
I whakaputaina:	MDPI AG, 2024-10-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Mitochondria-Targeted Liposomes for Drug Delivery to Tumor Mitochondria
mā: Aysegul Ekmekcioglu, me ētahi atu.
I whakaputaina: (2024)

Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate
mā: Hanan Refai, me ētahi atu.
I whakaputaina: (2017)

Preparation and characterization of an injectable thermosensitive hydrogel for simultaneous delivery of paclitaxel and doxorubicin
mā: Mahboubeh Rezazadeh, me ētahi atu.
I whakaputaina: (2018)

In Vitro and Preclinical Antitumor Evaluation of Doxorubicin Liposomes Coated with a Cholesterol-Based Trimeric β-D-Glucopyranosyltriazole
mā: Aline Teixeira Maciel e Silva, me ētahi atu.
I whakaputaina: (2023)

Preparation and Characterization of New Liposomes. Bactericidal Activity of Cefepime Encapsulated into Cationic Liposomes
mā: Maria Luisa Moyá, me ētahi atu.
I whakaputaina: (2019)

Pegylated liposomal doxorubicin in ovarian cancer
mā: Robert Strother, me ētahi atu.
I whakaputaina: (2009)

Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance
mā: Yinghuan Li, me ētahi atu.
I whakaputaina: (2020)

Preparation and physicochemical characterization of topical quercetin loaded liposome
mā: Neda Bavarsad, me ētahi atu.

Novel Worm-like Micelles for Hydrochloride Doxorubicin Delivery: Preparation, Characterization, and In Vitro Evaluation
mā: Ya-Ni Yang, me ētahi atu.
I whakaputaina: (2022)

Liposomal doxorubicin-induced palmoplantar erythrodysthesia syndrome
mā: Nidhi Yadav, me ētahi atu.
I whakaputaina: (2015)

Pegylated liposomal doxorubicin in the management of ovarian cancer
mā: Gabriella Ferrandina, me ētahi atu.
I whakaputaina: (2010)

Pharmacokinetics of a liposomal formulation of doxorubicin in rats
mā: Zongyu Liu, me ētahi atu.
I whakaputaina: (2017)

Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
mā: Kenan Aloss, me ētahi atu.
I whakaputaina: (2023)

Preparation and Characterization of Magnetic Solid Lipid Nanoparticles as a Targeted Drug Delivery System for Doxorubicin
mā: Abbas Soltani, me ētahi atu.
I whakaputaina: (2023)

Preparation and characterization of TiO2-PEG NPs loaded doxorubicin
mā: Zahra Sobhani, me ētahi atu.
I whakaputaina: (2019)

Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
mā: Dorniani D, me ētahi atu.
I whakaputaina: (2013)

Pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia
mā: Joana Moreira-Barros, me ētahi atu.
I whakaputaina: (2018)

Prolonged use of pegylated liposomal doxorubicin in gynecologic malignancies
mā: S. Yost, me ētahi atu.
I whakaputaina: (2019)

Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
mā: Zhen Yuan, me ētahi atu.
I whakaputaina: (2021)

Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma
mā: Mohsen Ghaferi, me ētahi atu.
I whakaputaina: (2022)

Preparation, characterization and in vitro cytotoxicity evaluation of free and liposome-encapsulated tylosin
mā: Mohammad Ehsan Saddiqi, me ētahi atu.
I whakaputaina: (2022)

Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil
mā: Al Asmari AK, me ētahi atu.
I whakaputaina: (2016)

Preparation and In Vitro Characterization of Enoxaparin Nano-liposomes through Different Methods
mā: Sarveen Palassi, me ētahi atu.
I whakaputaina: (2021)

Preparation and characterization of liposomes loaded with silver nanoparticles obtained by green synthesis
mā: Joel Toribio Espinoza, me ētahi atu.
I whakaputaina: (2021)

Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than DoxilⓇ
mā: Ruoshi Zhang, me ētahi atu.
I whakaputaina: (2020)

Multilayer-Coated Tablet of Clopidogrel and Rosuvastatin: Preparation and In Vitro/In vivo Characterization
mā: Ki-Soo Seo, me ētahi atu.
I whakaputaina: (2019)

The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery
mā: Simeng Xiao, me ētahi atu.
I whakaputaina: (2023)

Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
mā: E. V. Artamonova
I whakaputaina: (2016)

Chitosan-Coated Liposome Formulations for Encapsulation of Ciprofloxacin and Etoposide
mā: Rubén Gil-Gonzalo, me ētahi atu.
I whakaputaina: (2024)

A Novel Diosgenin-Based Liposome Delivery System Combined with Doxorubicin for Liver Cancer Therapy
mā: Lixia Chen, me ētahi atu.
I whakaputaina: (2022)

Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies
mā: Hamidreza Dorostkar, me ētahi atu.
I whakaputaina: (2023)

Doxorubicin Loaded Thermosensitive Magneto-Liposomes Obtained by a Gel Hydration Technique: Characterization and In Vitro Magneto-Chemotherapeutic Effect Assessment
mā: Stefan Nitica, me ētahi atu.
I whakaputaina: (2022)

Light-Activated Liposomes Coated with Hyaluronic Acid as a Potential Drug Delivery System
mā: Otto K. Kari, me ētahi atu.
I whakaputaina: (2020)

Morphological changes of doxorubicin-loaded liposomes observed by atomic force microscopy
mā: Naoki Takahashi, me ētahi atu.
I whakaputaina: (2016)

Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapy
mā: Jiang Yu, me ētahi atu.
I whakaputaina: (2020)

Mini review on emerging methods of preparation of liposome and its application as Liposome drug delivery systems
mā: Ateeq Rahman, me ētahi atu.
I whakaputaina: (2018)

Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies
mā: Tang Z, me ētahi atu.
I whakaputaina: (2019)

Preparation and physicochemical characterization of topical chitosan-based film containing griseofulvin-loaded liposomes
mā: Neda Bavarsad, me ētahi atu.
I whakaputaina: (2016)

Preparation, Characterization, and In Vivo Pharmacokinetic Study of the Supercritical Fluid-Processed Liposomal Amphotericin B
mā: Chang-baek Lim, me ētahi atu.
I whakaputaina: (2019)

Doxorubicin-Loaded Human Serum Albumin Submicron Particles: Preparation, Characterization and In Vitro Cellular Uptake
mā: Saranya Chaiwaree, me ētahi atu.
I whakaputaina: (2020)